COVID-19: UK-based SME offers recombinant protein production services to partners developing coronavirus diagnostics
A UK-based SME is offering its recombinant protein production expertise to companies, universities and research organisation developing diagnostic tests for coronavirus. The SME's technology enables production of good quantities of high quality protein in mammalian cell systems. It is envisaged that the partnerships will take the form of a commercial agreement with technical assistance, technical cooperation agreement or a research cooperation agreement.